Singapore Clinical Trial: An Open-Label Study to Investigate the Long-Term Effects of Acoramidis on Cardiac Function, Structure and Cardiac Amyloid Burden in Participants with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Singapore, Aug. 5 -- The Health Sciences Authority received information related to the study titled 'An Open-Label Study to Investigate the Long-Term Effects of Acoramidis on Cardiac Function, Structure and Cardiac Amyloid Burden in Participants with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)'. The following are the other relevant details related to the trial:

Therapeutic Area: Cardiology

Trial Centre(s): National Heart Centre National University Hospital

Trial Status: NA

Principal Investigator(s): Dr Khoo Chun Yuan Dr Lin Weiqin

Published by HT Digital Content Services with permission from Health Daily Digest....